Related Experiment Video
Updated: May 26, 2025

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology
Published on: October 3, 2016
Anthrax: Transmission, Pathogenesis, Prevention and Treatment
Nitika Sangwan1, Aakriti Gangwal2, Preksha Jain3
1Department of Biomedical Science, Bhaskaracharya College of Applied Sciences, University of Delhi, Delhi 110075, India.
Bacillus anthracis forms resistant spores for survival and transmission, causing anthrax through its potent toxin. Research explores its pathogenesis, prevention, vaccines, and potential cancer therapeutic applications.
Area of Science:
- Microbiology
- Pathogen Biology
- Toxicology
Background:
- Bacillus anthracis forms highly resistant spores, enabling long-term survival and transmission via soil or animal products.
- Anthrax infection occurs through cutaneous, inhalation, or gastrointestinal routes, leading to severe disease.
- Anthrax toxin is a critical virulence factor responsible for host cell death.
Purpose of the Study:
- To review the sporulation, transmission, and pathogenesis of Bacillus anthracis.
- To summarize current prevention and treatment strategies for anthrax.
- To explore the potential of anthrax toxin as a cancer therapeutic.
Main Methods:
- Literature review of scientific publications on Bacillus anthracis.
- Analysis of existing data on anthrax pathogenesis and virulence factors.
- Examination of current vaccine efficacy and therapeutic applications.
Main Results:
- Bacillus anthracis pathogenesis involves spore formation, transmission, and toxin-mediated host cell damage.
- Protein kinases and phosphatases play a role in B. anthracis toxin production and virulence.
- FDA-approved vaccines (BioThrax, CYFENDUS) exist for anthrax prevention.
Conclusions:
- Understanding B. anthracis sporulation and pathogenesis is crucial for disease control.
- Anthrax toxin shows promise as a novel therapeutic agent for cancer treatment.
- Continued research is needed to enhance anthrax prevention and treatment strategies.
More Related Videos
Related Concept Videos
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

